These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 19424970)

  • 21. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
    Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
    J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
    Li P; Morris DL; Willcox BE; Steinle A; Spies T; Strong RK
    Nat Immunol; 2001 May; 2(5):443-51. PubMed ID: 11323699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
    Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.
    Hedlund M; Stenqvist AC; Nagaeva O; Kjellberg L; Wulff M; Baranov V; Mincheva-Nilsson L
    J Immunol; 2009 Jul; 183(1):340-51. PubMed ID: 19542445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and characterization of a porcine UL16 binding protein (ULBP)-like cDNA.
    García-Borges CN; Phanavanh B; Saraswati S; Dennis RA; Crew MD
    Mol Immunol; 2005 Apr; 42(6):665-71. PubMed ID: 15781110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.
    Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL
    Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F; van Andel E; Andresen L; Skov S
    Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
    Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
    Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B; Khar A
    Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
    Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells.
    Kubin M; Cassiano L; Chalupny J; Chin W; Cosman D; Fanslow W; Müllberg J; Rousseau AM; Ulrich D; Armitage R
    Eur J Immunol; 2001 May; 31(5):1428-37. PubMed ID: 11465099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.
    Bacon L; Eagle RA; Meyer M; Easom N; Young NT; Trowsdale J
    J Immunol; 2004 Jul; 173(2):1078-84. PubMed ID: 15240696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands.
    Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E
    Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V
    Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
    Hilpert J; Grosse-Hovest L; Grünebach F; Buechele C; Nuebling T; Raum T; Steinle A; Salih HR
    J Immunol; 2012 Aug; 189(3):1360-71. PubMed ID: 22730533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.
    Song H; Park H; Park G; Kim YS; Lee HK; Jin DH; Kang HS; Cho DH; Hur D
    Oncol Rep; 2014 Jul; 32(1):425-30. PubMed ID: 24841552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS; Hwang YK; Lee JK
    Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.